Skip to main content
Clinical Trials/NCT01651013
NCT01651013
Active, not recruiting
Not Applicable

Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras

National Cancer Institute, Naples4 sites in 1 country500 target enrollmentOctober 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metastatic Colorectal Cancer
Sponsor
National Cancer Institute, Naples
Enrollment
500
Locations
4
Primary Endpoint
Percentage of patients with K-Ras mutation
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to describe the treatments received and outcomes of patients with metastatic colorectal cancer, what percentage of these patients have K-Ras mutation of the tumor, and to describe the costs of treatments. Information will also be collected regarding risk factors, variables among treatment centers and patients, and explorative analyses will be done to try to identify factors that impact prognosis and factors that predict tolerability and response to treatment.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
December 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
National Cancer Institute, Naples
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Histologic diagnosis colorectal carcinoma
  • Metastatic disease
  • Signed informed consent

Exclusion Criteria

  • Prior treatment of metastatic colorectal cancer
  • Refusal or incapability of providing informed consent

Outcomes

Primary Outcomes

Percentage of patients with K-Ras mutation

Time Frame: 2 years

percentage of patients enrolled in a clinical trial

Time Frame: two years

percentage of patients who undergo K-Ras mutation study

Time Frame: 2 years

Study Sites (4)

Loading locations...

Similar Trials